Waner Wu

Waner Wu

Auto-generated profile, based on publicly available information

Waner Wu

Assisted Reproductive Technology Unit, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong , Hong Kong SAR

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
WWWaner Wu
Waner Wu
NXNa Xu
Na Xu
XZXuan Zhou
Xuan Zhou
LLLiang Liu
Liang Liu
YTYaxian Tan
Yaxian Tan
XLXiaoli Liu
Xiaoli Liu
Introduction: While the acquisition of mutations in the ABL1 kinase domain (KD) has been identified as a common mechanism behind tyrosine kinase inhibitor (TKI) resistance, recent genetic studies have revealed that patients with TKI resistance or intolerance frequently harbor one or more genetic alterations implicated in myeloid malignancies. This suggests that additional mutations other than ABL1 KD mutations might contribute to disease progression. Methods: We performed targeted-capture sequencing of 127 known and putative cancer-related genes of 63 patients with CML using next-generation sequencing (NGS), including 42 patients with TKI resistance and 21 with TKI intolerance. Results: The differences in the number of mutations between groups had no statistical significance. This could be explained in part by not all of the patients having achieved major molecular remission in the early period as expected. Overall, 66 mutations were identified in 96.8% of the patients, most frequently in the KTM2C (31.82%), ABL1 (31.82%), FAT1 (25.76%), and ASXL1 (22.73%) genes. CUX1, KIT, and GATA2 were associated with TKI intolerance, and two of them (CUX1, GATA2) are transcription factors in which mutations were identified in 82.61% of patients with TKI intolerance. ASXL1 mutations were found more frequently in patients with ABL1 KD mutations (38.1% vs 15.21%, P=0.041). Although the number of mutations was low, pairwise interaction between mutated genes showed that ABL1 KD mutations cooccurred with SH2B3 mutations (P< 0.05). In Kaplan–Meier analyses, only TET2 mutations were associated with shorter progression-free survival (P=0.026). Conclusion: Our data suggested that the CUX1, KIT, and GATA2 genes may play important roles in TKI intolerance. ASXL1 and TET2 mutations may be associated with poor patient prognosis. NGS helps improving the clinical risk stratification, which enables the identification of patients with TKI resistance or intolerance in the era of TKI therapy.

27 May 2025 in Fertility & Reproduction
Verified
Journal Article
Open access
DCDavid Yiu Leung Chan
David Yiu Leung Chan
MXMurong Xu
Murong Xu
WWWaner Wu
Waner Wu
KFKa Kei Fung
Ka Kei Fung
LZLinyao Zhang
Linyao Zhang
PCPui Wah Jacqueline Chung
Pui Wah Jacqueline Chung
Background: Frozen embryo transfer (FET) has been a routine assisted reproductive technology (ART) procedure since the first FET by slow freezing. It is estimated that more than 2 million FET cycles are performed worldwide each year. The stepwise removal of cytotoxic cryoprotectants and rehydration in serial osmotic solutions has been a fundamental principle, but the entire process is time-consuming and labor-intensive. Methods: A two-phase study was performed. In Phase 1 (technical validation), four culture media and phosphate-buffered saline (PBS)-only control with specific osmolality (270 ± 10 mOsm/KG) were used. Survival rates were determined by embryo movement and re-expansion under time-lapse imaging. The technical compatibility of repeated direct warming and repeated biopsies for preimplantation genetic tests was investigated. In Phase 2 (clinical application), 20 and 76 patients were recruited for direct and conventional warming. Cost-effectiveness analyses were performed. Results: In Phase 1, all culture media supported 100% survival rates ([ ] = 52), even in PBS ([ ] = 11). Revived blastocysts could re-expand as a conventional method. Directly rehydrated and warmed blastocysts in culture medium also survived from direct warming, trophectoderm biopsy, second vitrification, and second direct warming with the second biopsy, indicating compatibilities with conventional PGT procedures ([ ] = 13). In Phase 2, nonsignificant but higher implantation rates and clinical pregnancy rates were obtained from direct warming compared with conventional warming (61.9% vs. 38.5%, 60.0% vs. 39.5%), leading to healthy live births (LBs) (45% vs. 36.8%). Miscarriage rates were also comparable (three vs. two incidences). Cost-effectiveness analyses showed that direct warming could save 42% in consumable costs and 90% in labor hours. Conclusions: Current results showed that direct warming/rehydration is a feasible way, and gradual cryoprotectant removal and rehydration were unnecessary for human blastocyst warming survival. In this small sample-size pilot study, direct-warmed blastocysts supported all clinical outcomes equivalent to conventional procedures with saved time and money. Further multicenter clinical trials are needed to provide convincing resolutions on the direct warming and rehydration of human blastocysts.

6 July 2026 in Human Reproduction
Verified
Journal Article
Open access
WWWaner Wu
Waner Wu
YSYitong Shen
Yitong Shen
SSShenghai Shen
Shenghai Shen
MXMurong Xu
Murong Xu
LZLinyao Zhang
Linyao Zhang
DCDavid Yiu Leung Chan
David Yiu Leung Chan
STUDY QUESTION: Does direct warming preserve embryonic developmental competence and molecular integrity as well as conventional multi-step warming in vitrified human and mouse cleavage-stage embryos? SUMMARY ANSWER: Direct warming yielded comparable developmental and molecular outcomes to conventional warming in both mouse and human cleavage-stage embryos. WHAT IS KNOWN ALREADY: Conventional embryo warming uses stepwise cryoprotectant dilution to minimize toxicity and osmotic shock. Direct warming methods have been proposed, but their impact on post-warming development and the molecular comparison remains unclear. STUDY DESIGN, SIZE, DURATION: This is a controlled experimental study conducted over 18 months. A total of 490 vitrified mouse embryos and 15 donated human embryos were tested either in direct or conventional warming group. A subset underwent embryo transfer and follow-up. Parallel transcriptomic and DNA methylation profiling was performed on mouse and donated human embryos. PARTICIPANTS/MATERIALS, SETTING, METHODS: Mouse cleavage-stage embryos (C57BL/6J) were vitrified and randomly assigned to direct (n = 265) or conventional (n = 225) warming. Post-warming survival and blastocyst formation were assessed in vitro. A subset (n = 211) underwent embryo transfer to evaluate implantation, live birth, and postnatal development to Day 21. For molecular analysis, pooled mouse embryos from fresh, conventional, and direct groups were analyzed by bulk RNA-seq and bisulfite sequencing. Ten vitrified human embryos (n = 5 per group) were analyzed individually by scRNA-seq and scBS-seq. All procedures were conducted under standard IVF lab conditions with ethical approval. MAIN RESULTS AND THE ROLE OF CHANCE: Direct warming in mouse achieved comparable survival (95.8% vs 93.8%), blastocyst formation (88.6% vs 88.2%), implantation (82.5% vs 83.0%), and live birth rates (69.6% vs 71.1%) to conventional warming (all P > 0.05). Offspring showed similar growth, developmental milestones, and organ histology. Mouse transcriptome and methylome profiles revealed minimal differences and no significant pathway enrichment. In human embryos, ion channel-related gene variability was observed but without coordinated pathway disruption. Global methylation levels remained within expected developmental ranges. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: While the mouse model enables in vivo validation, species-specific differences in embryo size, membrane properties, and development may limit generalizability. As all embryos were cultured under optimized conditions, caution is advised when extrapolating to diverse clinical settings. WIDER IMPLICATIONS OF THE FINDINGS: To our knowledge, this is the first study to provide multi-level evidence supporting the safety and efficacy of direct warming as an alternative to conventional multi-step embryo warming protocols. By incorporating in vivo reproductive outcomes, postnatal development, and molecular profiling, it strengthens current evidence on the feasibility of this approach. The absence of pathway-level disruptions in transcriptome and methylome datasets suggests that direct warming does not impair essential developmental programs. These findings may support the clinical use of simplified warming procedures, especially for cleavage-stage embryo transfer or in resource-limited settings. However, further clinical studies are warranted to confirm long-term safety in humans. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Collaborative Research Fund (CRF-C4007-24E), and Early Career Scheme (ECS-26103623) from the University Grants Committee (UGC), and Health and Medical Research Fund (HMRF 12230736) from the Hong Kong Government. The authors report no competing interests. TRIAL REGISTRATION NUMBER: N/A.